Somatostatin analogue continuation upon progression in patients with gastroenteropancreatic neuroendocrine tumour (SAUNA trial) : a randomised controlled trial protocol
Source
BMJ open - ISSN 2044-6055-15:7 (2025) p. 1-11
Efficacy and safety of capecitabine-temozolomide (CAPTEM) regimen in patients with neuroendocrine neoplasms - experience from NETwerk, a Belgian ENETS Center of Excellence
Source
Acta gastro-enterologica belgica - ISSN 1784-3227-88:2 (2025) p. 119-127
Long-term effects of the COVID-19 pandemic for patients with cancer
Source
Quality of life research - ISSN 0962-9343-33:10 (2024) p. 2845-2853
The quest for circulating biomarkers in neuroendocrine neoplasms : a clinical perspective
Source
Current treatment options in oncology - ISSN 1527-2729-24:12 (2023) p. 1833-1851